Generation of Novel Plasmids inEscherichia coliS17-1(pSUP106)
β Scribed by Nitish R. Mahapatra; Sajalendu Ghosh; Partha K. Sarkar; Pataki C. Banerjee
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 213 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0343-8651
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
HIV-1 integrase (IN), one of the essential enzymes in HIV infection, has been validated as a target for HIV treatment. While more than 20 drugs have been approved by the FDA to treat HIV/AIDS, only one drug, Raltegravir (1), was approved as an IN inhibitor. The rapid mutation of the virus, which lea
A new and reliable route to a new class of LFA-1 inhibitors such as (2) has been developed. A key aspect of this route is the transformation of amino amide 5 into iodide 3 in four steps. Iodide 3 is a key advanced intermediate used in the synthesis of all second-generation 1H-imidazo[1,2-a]imidazol-